User:Libby EMAcomm/Working page 2020

Here are my edits in 2020, please comment:

Sofosbuvir: 3/2 added recommendation of 2016 review under 'Side effects'

Daclatasvir: 3/2 added recommendation of 2016 review under 'Adverse effects'

Simeprevir: 3/2 added recommendation of 2016 review under 'Adverse effects'

Ombitasvir/paritaprevir/ritonavir: 3/2 added recommendation of 2016 review under 'Side effects'

Ledipasvir/sofosbuvir: 3/2 added recommendation of 2016 review under 'Side effects'

Dasabuvir: 3/2 added recommendation of 2016 review under 'Adverse effects'